Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Statin treatment and muscle symptoms: a series of randomised, placebo controlled N-of-1 trials

ARMITAGE J., (2020), BMJ: British Medical Journal

Comparison of four methods to measure haemoglobin concentrations in whole blood donors ( COMPARE ): A diagnostic accuracy study

Bell S. et al, (2020), Transfusion Medicine

Use of run-in periods in randomized trials

Huo X. and ARMITAGE J., (2020), JAMA: Journal of the American Medical Association

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Hammami I. et al, (2019), EUROPEAN HEART JOURNAL, 40, 265 - 265

Serious Adverse Effects of Extended-Release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.

Haynes R. et al, (2019), Clin Ther

Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): A multicenter, randomized, placebo controlled trial.

Kitas GD. et al, (2019), Arthritis Rheumatol

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials.

Offer A. et al, (2019), JAMA Netw Open, 2

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1540 - 1550

Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.

Clarke RJ. et al, (2018), JAMA Cardiol, 3, 781 - 782

Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.

Beveridge LA. et al, (2018), J Am Heart Assoc, 7

Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.

Berlanga-Taylor AJ. et al, (2018), EBioMedicine, 31, 133 - 142

Ezetimibe: Likely to Be Beneficial For All.

Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

Bowman L. et al, (2018), Am Heart J, 198, 135 - 144

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.

Parish S. et al, (2018), Circ Genom Precis Med, 11

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.

Herrett E. et al, (2017), BMJ Open, 7

Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.

Di Angelantonio E. et al, (2017), Lancet, 390, 2360 - 2371

Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D).

Tomson J. et al, (2017), J Am Heart Assoc, 6

Genetic approaches to elucidating our understanding of therapeutic targets

STIBY A. et al, (2017)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?